Antiviral drug remdesivir prevents COVID-19 progression in monkeys
The study, led by the NIH's National Institute of Allergy and Infectious Diseases involved two groups of six rhesus macaque monkeys that were intentionally infected with the respiratory disease.
An ampule of drug Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues(photo credit: ULRICH PERREY/POOL VIA REUTERS)ByALEX WINSTON
